Search / Trial NCT06615401

Understanding Perceived Access and Receipt of Gender-affirming Treatments Among Transgender Veterans

Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Sep 23, 2024

Trial Information

Current as of December 21, 2024

Recruiting

Keywords

Transgender Gender Dysphoria Gender Affirming Treatment

ClinConnect Summary

This clinical trial is focused on understanding how transgender veterans access and receive gender-affirming treatments (GATs), which are important medical care options that help reduce the distress some individuals feel when their gender identity doesn’t match their birth sex. The study aims to discover what types of GATs transgender veterans are receiving, the challenges they face in getting these treatments through the VA (Veterans Affairs) and community care, and how to improve access to these necessary services. By working with a group of stakeholders, the researchers hope to create strategies that will help overcome barriers and enhance support for transgender veterans seeking GATs.

To participate in this study, veterans need to have a documented diagnosis of gender identity disorder and identify as transgender. There are no specific exclusions, meaning anyone who meets these criteria can join. Participants can expect to share their experiences and insights, which will help shape better access to gender-affirming care in the future. This research is important in promoting health equity for transgender veterans, ensuring they receive the care they need and deserve.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All veterans with documentation of gender identity disorder diagnoses
  • Self-reported gender identity as transgender and relevant transgender-related health factor
  • Exclusion Criteria:
  • None

Trial Officials

Guneet K. Jasuja, PhD

Principal Investigator

VA Bedford HealthCare System, Bedford, MA

About Va Office Of Research And Development

The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.

Locations

Bedford, Massachusetts, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0